CTMC has operated for two and a half years without any instances of therapy mix-ups, a success attributed by Bock to the use of digital infrastructure to ensure the correct therapy reaches the correct patient.

Authors

• Person: Not available Organization: Drug Target Review
  New cell therapy model accelerates cancer treatment development

Sources

• New cell therapy model accelerates cancer treatment development www.drugtargetreview.com Drug Target Review via serper

Referenced by nodes (1)

• CTMC entity